Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations
RSC Advances · 2026 · 16 (37) · 39847-39857
DOI: 10.1039/d6ra02851a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Yun Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Yongkang First People's Hospital and School of Pharmacy, Hangzhou Medical College Hangzhou 310013 China wzuny@hmc.edu.cn xuxiangwei@hmc.ed…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
A series of compounds by hybridizing the natural product Genistein and the non-nucleoside METTL3 inhibitor STM2457 were designed and screened by molecular docking, and H1 was synthesized and evaluated to be a potential METTL3 inhibitor.
Autor:innen und Institutionen
- Affiliated Yongkang First People's Hospital and School of Pharmacy, Hangzhou Medical College Hangzhou 310013 China wzuny@hmc.edu.cn xuxiangwei@hmc.edu.cn.
- School of Public Health, Hangzhou Medical College Hangzhou 310013 China.
- School of Clinical Medicine, Hangzhou Medical College Hangzhou 310013 China.
- School of Rehabilitation, Hangzhou Medical College Hangzhou 310013 China.
- Yongkang First People's Hospital Yongkang 321306 China.
ORCID-Profile: Zunyuan Wang
Zitieren
APA
Zhang, Y., Chen, M., He, Y., Chen, Q., Han, H., Zhang, X., Qian, Y., Jiang, H., Xu, X., & Wang, Z. (2026). Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations. RSC Advances, 16(37), 39847-39857. https://doi.org/10.1039/d6ra02851a
Vancouver
Zhang Y, Chen M, He Y, Chen Q, Han H, Zhang X, et al. Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations. RSC Advances. 2026;16(37):39847-39857. doi:10.1039/d6ra02851a
BibTeX
@article{Zhang2026,
author = {Zhang, Yun and Chen, Mengyan and He, Yanwen and Chen, Qinlan and Han, Hongdi and Zhang, Xianling and Qian, Yihan and Jiang, Haiying and Xu, Xiangwei and Wang, Zunyuan},
title = {Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {37},
pages = {39847--39857},
doi = {10.1039/d6ra02851a}
}
EUVIMED